Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Gigolashvili T | Update on antifungal therapy. | 1999 May-Jun | Cancer Pract | pmid:10352080 |
Ramaswamy M et al. | Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma. | 1999 | Antimicrob. Agents Chemother. | pmid:10348764 |
Oakley KL et al. | Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. | 1999 | Antimicrob. Agents Chemother. | pmid:10223948 |
Levy-Polack MP et al. | Incidence of oral complications and application of a preventive protocol in children with acute leukemia. | 1998 Sep-Oct | Spec Care Dentist | pmid:10219183 |
Lövgren T and Salmela I | In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents. | 1978 | Acta Pathol Microbiol Scand B | pmid:102108 |
Ellepola AN and Samaranayake LP | The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. | 1998 | Oral Dis | pmid:10200705 |
Carvalho JC et al. | Anti-inflammatory activity of the crude extract from the fruits of Pterodon emarginatus Vog. | 1999 | J Ethnopharmacol | pmid:10197747 |
Taylor CT et al. | Berberine inhibits ion transport in human colonic epithelia. | 1999 | Eur. J. Pharmacol. | pmid:10096776 |
Tollemar J et al. | Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. | 1999 | Bone Marrow Transplant. | pmid:10084261 |
Ellepola AN and Samaranayake LP | The in vitro post-antifungal effect of nystatin on Candida species of oral origin. | 1999 | J. Oral Pathol. Med. | pmid:10069538 |